PPT-A Randomized Trial Comparing a Polymer-Free Coronary Drug-Eluting Stent With an Ultra-Thin

Author : layla | Published Date : 2023-07-09

Bioresorbable PolymerBased DrugEluting Stent in an AllComers Patient Population Lisette Okkels Jensen Michael Maeng Bent Raungaard Johnny Kahlert Julia Ellert

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "A Randomized Trial Comparing a Polymer-F..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

A Randomized Trial Comparing a Polymer-Free Coronary Drug-Eluting Stent With an Ultra-Thin: Transcript

Bioresorbable PolymerBased DrugEluting Stent in an AllComers Patient Population Lisette Okkels Jensen Michael Maeng Bent Raungaard Johnny Kahlert Julia Ellert Lars Jakobsen . Eaton's 4Dimension strut system changes how installers will build and install support systems for electrical, mechanical, plumbing, HVAC and data centers in new and retrot commercial The revolutionar , . and Bio-. Absorbables. . John Wainwright, Ph.D.. Sr. R&D . Manager, Medtronic plc. WLNC 06/08/15. Some of the technologies/devices discussed in this talk are not approved in the US . Reasons for Coatings and Surface Modifications. Dalby. , Munich, ESC2008. Update about the OCT data of the . Translumina. DES and competitors. A . Randomised. . optical. . coherence. . tomography. . study. . to. . determine. 90 . day. . stent. January 15. th. , 2016. 10h30. What is/are the best antithrombotic treatment(s) in case of stent thrombosis?. A. ). . 75mg . of . clopidogrel. B). 150mg . of . clopidogrel. C). 90mg x 2 . of . ticagrelor. , . and Bio-. Absorbables. . John Wainwright, Ph.D.. Sr. R&D . Manager, Medtronic plc. WLNC 06/08/15. Some of the technologies/devices discussed in this talk are not approved in the US . Reasons for Coatings and Surface Modifications. , . and Bio-. Absorbables. . John Wainwright, Ph.D.. Sr. R&D . Manager, Medtronic plc. WLNC 06/08/15. Some of the technologies/devices discussed in this talk are not approved in the US . Reasons for Coatings and Surface Modifications. E. xpandable. . Stent. . Balloon. . Expandable. . Stent. Balloon-Expandable . Stents – Overview . Balloon-Expandable. . Stents. – . Overview. . Zilver. Stent with history and development. J. Hausleiter, I. Ott, M. Fusaro, T. Ibrahim, A. Schömig,. . A. Kastrati. . Deutsches Herzzentrum & 1st Med. Klinik rechts der Isar,. Technische Universität Munich,. Germany. ISAR-CABG:. Randomized, Superiority Trial of . Sunil V. Rao MD FSCAI. Duke University Health System. Durham VA Health System. Disclosures . Institutional research funding. Svelte Inc. Shockwave Medical. Bayer . No consulting RWI . Thanks to Ajay . vs. 1.46 mm, . p < 0.0001; . IVUS showed lower post-procedure mean lumen area in BVS arm (4.9 vs. 5.7 mm. 2. , . p < 0.001. ). 1-year scaffold thrombosis in . two . BVS . patients; . no stent thrombosis in DES arm. Comparing Second Generation Drug-eluting Stents Using. Either Biodegradable Polymer or Durable Polymer. The NOBORI . Biolimus. -Eluting versus XIENCE/PROMUS . Everolimus. -eluting Stent Trial (NEXT). Background Drug-eluting stentsrepresent a major advance in the in the represent a major advance in the in the field of field of ofinterventional cardiology & the interventional cardiology & th Zach Eddy, Category Advisor. 2. What are drug-eluting coronary stents?. Design. Expandable wire mesh tube. Coated with an antiproliferative drug. Pre-mounted on a balloon catheter delivery system. Function. Polymer-Based DES Compared with an Ultra-Thin Strut Bioresorbable . Polymer-Based DES in an All-Comers Patient Population. Clemens von Birgelen, MD PhD FESC. Thoraxcentrum. . Twente. , MST, . Enschede.

Download Document

Here is the link to download the presentation.
"A Randomized Trial Comparing a Polymer-Free Coronary Drug-Eluting Stent With an Ultra-Thin"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.